BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tandon P, Walling A, Patton H, Taddei T. AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review. Clinical Gastroenterology and Hepatology 2021;19:646-656.e3. [DOI: 10.1016/j.cgh.2020.11.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Walling AM, Ast K, Harrison JM, Dy SM, Ersek M, Hanson LC, Kamal AH, Ritchie CS, Teno JM, Rotella JD, Periyakoil VS, Ahluwalia SC. Patient-Reported Quality Measures for Palliative Care: The Time is now. J Pain Symptom Manage 2023;65:87-100. [PMID: 36395918 DOI: 10.1016/j.jpainsymman.2022.11.001] [Reference Citation Analysis]
2 Taddei TH, Jou JH. When to Stop Screening-Liver Cancer. Am J Gastroenterol 2023. [PMID: 36563304 DOI: 10.14309/ajg.0000000000002120] [Reference Citation Analysis]
3 Jaffe A, Taddei TH, Giannini EG, Ilagan-Ying YC, Colombo M, Strazzabosco M. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook. Liver Int 2022;42:2607-19. [PMID: 36161463 DOI: 10.1111/liv.15432] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tian T, Guo J, Hu J, Hu Y, Guo P, Yu X. Advanced hepatocellular carcinoma and palliative care: a scoping review. BMJ Support Palliat Care 2022. [DOI: 10.1136/spcare-2022-003798] [Reference Citation Analysis]
5 Arney J, Gray C, Walling AM, Clark JA, Smith D, Melcher J, Asch S, Kanwal F, Naik AD. Two mental models of integrated care for advanced liver disease: qualitative study of multidisciplinary health professionals. BMJ Open 2022;12:e062836. [PMID: 36691142 DOI: 10.1136/bmjopen-2022-062836] [Reference Citation Analysis]
6 Rogal SS, Hansen L, Patel A, Ufere NN, Verma M, Woodrell CD, Kanwal F. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology 2022;76:819-53. [PMID: 35103995 DOI: 10.1002/hep.32378] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
7 Shaw J, Beyers L, Bajaj JS. Inadequate practices for hepatic encephalopathy management in the inpatient setting. J Hosp Med 2022;17 Suppl 1:S8-S16. [PMID: 35972037 DOI: 10.1002/jhm.12897] [Reference Citation Analysis]
8 Ufere NN, Patzer RE, Kavalieratos D, Louissaint J, Kaplan A, Cross SH. Rural-Urban Disparities in Mortality From Cirrhosis in the United States From 1999 to 2019. Am J Gastroenterol 2022;117:1162-5. [PMID: 35213405 DOI: 10.14309/ajg.0000000000001712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Patel K, Tandon P, Hernaez R. Palliative Care in the Patient With Acute‐on‐Chronic Liver Failure. Clinical Liver Disease. [DOI: 10.1002/cld.1201] [Reference Citation Analysis]
10 Berry P, Kotha S. Improving end of life care in liver disease. J Hepatol 2022;76:1225-6. [PMID: 35063299 DOI: 10.1016/j.jhep.2021.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Whitsett MP, Ufere NN, Patel A, Shea JA, Jones CA, Fix OK, Serper M. Palliative care experience and perceived gaps in training among transplant hepatology fellows: A national survey. Hepatol Commun 2022. [PMID: 35411683 DOI: 10.1002/hep4.1939] [Reference Citation Analysis]
12 Tombazzi CR, Howe CF, Slaughter JC, Obstein KL. Rate of and Factors Associated with Palliative Care Referral among Patients Declined for Liver Transplantation. J Palliat Med 2022. [PMID: 35333610 DOI: 10.1089/jpm.2021.0403] [Reference Citation Analysis]
13 Hui Y, Li N, Yu Z, Li C, Wang X, Li Y, Sun M, Yang W, Guo G, Fan X, Lin L, Cui B, Chen X, Wang B, Zhang J, Sun C. Health-Related Quality of Life and Its Contributors According to a Preference-Based Generic Instrument in Cirrhosis. Hepatol Commun 2021. [PMID: 34558226 DOI: 10.1002/hep4.1827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Rivera-Esteban J, Armandi A, Augustin S, Bugianesi E. Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis. Liver Int 2021;41:1999-2008. [PMID: 34242466 DOI: 10.1111/liv.15013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Ufere NN. Advance Care Planning and Goals of Care Discussions in Advanced Liver Disease. Curr Hepatology Rep 2021;20:77-84. [DOI: 10.1007/s11901-021-00565-x] [Reference Citation Analysis]
16 Biggins SW, Angeli P, Garcia-Tsao G, Ginès P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014-48. [PMID: 33942342 DOI: 10.1002/hep.31884] [Cited by in Crossref: 92] [Cited by in F6Publishing: 69] [Article Influence: 46.0] [Reference Citation Analysis]
17 Orman ES, Johnson AW, Ghabril M, Sachs GA. Hospice care for end stage liver disease in the United States. Expert Rev Gastroenterol Hepatol 2021;15:797-809. [PMID: 33599185 DOI: 10.1080/17474124.2021.1892487] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]